-
PBLA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Panbela Therapeutics (PBLA)
Company Profile
Quarter (USD) | Sep 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 142.00 k | 142.00 k | 142.00 k | 142.00 k | 142.00 k | 142.00 k |
Cash burn (monthly) | 812.00 k | 424.42 k | 2.39 mm | 2.34 mm | 706.67 k | 1.47 mm |
Cash used (since last report) | 2.29 mm | 1.20 mm | 6.74 mm | 6.58 mm | 1.99 mm | 4.14 mm |
Cash remaining | -2.15 mm | -1.05 mm | -6.59 mm | -6.44 mm | -1.85 mm | -3.99 mm |
Runway (months of cash) | -2.6 | -2.5 | -2.8 | -2.8 | -2.6 | -2.7 |
13F holders | Current |
---|---|
Total holders | 9 |
Opened positions | 2 |
Closed positions | 14 |
Increased positions | 0 |
Reduced positions | 6 |
13F shares | Current |
---|---|
Total value | 945.12 mm |
Total shares | 1.00 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Lind Global Fund II | 590.00 k | $0.00 |
Sabby Management | 235.82 k | $542.38 mm |
Walleye Capital | 94.54 k | $217.43 mm |
Hudson Bay Capital Management | 76.00 k | $174.80 mm |
Tower Research Capital | 3.71 k | $8.54 mm |
UBS UBS | 823.00 | $1.89 mm |
MS Morgan Stanley | 26.00 | $60.00 k |
BAC Bank of America | 2.00 | $5.00 k |
Advisor | 2.00 | $4.00 k |
Proequities | 0.00 | $0.00 |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Oct 24 | Simpson Jennifer K. | Stock Option Common Stock | Grant | Acquire A | No | No | 0.389 | 72,800 | 28.32 k | 72,800 |
1 Oct 24 | Horvath Susan | Stock Option Common Stock | Grant | Acquire A | No | No | 0.389 | 25,480 | 9.91 k | 25,480 |
8 Nov 23 | The Goldman Sachs Group, Inc. | Common Stock | Sell | Dispose S | Yes | No | 0.71 | 72,874 | 51.74 k | 397,954 |